Enrolling Clinical Studies
Healthy Participants Wanted for a COVID-19 Clinical Trial
This study will evaluate the safety, tolerability, immunogenicity and safety of a variantadapted RNA vaccine against COVID-19 in healthy adults 50 through 64 years of age.
Requirements:
• Male or female between 50 and 64 years of age.
• Healthy participants or participants with preexisting stable disease.
• No tested positive for COVID-19 or have received this vaccine in the last 3 months.
• No participants that has received any other vaccine in the last 30 days.
• No history of severe reactions associated with a vaccine or anaphylaxis allergy.
• No participants with Cancer, HIV, Asthma, COPD, Chronic kidney disease, Heart Conditions.
• No participants with Diabetes Type I and Type II, Fatty Liver, Cirrhosis.
• No participants with Depression, Schizophrenia, Parkinson’s, ADHD.
• No smoking, current or former participants.
• Participants must have a BMI equal to or less than 30kg/2.
• No women who are pregnant or breastfeeding.
• Subject must have a valid ID and not be participating in another study in the last 30 days.
Study Duration:
This study contains a total of 4 office visits over a period of 6 months.
Participants must complete an E-dairy for 7 days
Compensation:
Participants may receive up to $850 in compensation for time and travel. The study includes 4 in-person visits and completion of an e-diary during participation.